Nuwellis Announces the Submission of the AVOID-HF Clinical Analysis as a Late Breaking Clinical Trial at HFSA
Go back to Nuwellis Announces the Submission of the AVOID-HF Clinical Analysis as a Late Breaking Clinical Trial at HFSA| Baxter International Inc. (NYSE: BAX) | Delayed: 22.93 +0.13 (0.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.80 | 52 Week High | $50.16 | |||
| Open | $22.99 | 52 Week Low | $34.06 | |||
| Day High | $23.08 | P/E | 6.27 | |||
| Day Low | $22.56 | EPS | $3.66 | |||
| Volume | 11,747,739 | |||||
| (NASDAQ: NUWE) | Delayed: 0.87 -0.03 (3.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.90 | 52 Week High | $ | |||
| Open | $0.88 | 52 Week Low | $ | |||
| Day High | $0.89 | P/E | N/A | |||
| Day Low | $0.84 | EPS | $ | |||
| Volume | 502,522 | |||||
